During the COVID-19 pandemic, researchers at ETH Zurich began testing wastewater for traces of SARS-CoV-2. Now, years later, that same infrastructure is being used to track a much wider range of viruses, providing real-time data that helps hospitals and public health authorities anticipate infection waves before they overwhelm emergency rooms.

Tanja Stadler, a professor at ETH Zurich's Department of Biosystems Science and Engineering and head of the department since February 2026, told ETH News that the project has evolved far beyond its original purpose. "At the start of the pandemic, we aimed at detecting SARS-CoV-2 in wastewater as early as possible," she said. Working with Eawag, the aquatic research institute of the ETH Domain, the team compared wastewater data with coronavirus test results and found that wastewater monitoring could reliably track infection waves, often faster than relying on test results alone.

After the pandemic, the team extended the methods to respiratory syncytial virus (RSV) and influenza. RSV, which Stadler noted is less well-known than SARS-CoV-2 or influenza, can cause severe respiratory illness in infants and elderly people, sometimes leading to hospitalisation or death. The monitoring now goes beyond simply detecting whether these viruses are present. "We're in particular assessing whether for example antibodies against the viruses or vaccines are still effective," Stadler explained.

The data is made publicly available through a digital platform called WISE. According to Stadler, the primary users are public health authorities and hospitals, which use the information to plan for rising infection rates. Statistical methods allow forecasting of trends for one to three weeks, provided the epidemiological dynamics remain consistent. "Whenever our servers have a short downtime, we receive in particular emails from hospitals," Stadler said. "Thus, we know that our platform is used to anticipate waves of RSV, influenza or COVID." Pharmaceutical companies also use the data to assess which viruses are circulating and how vaccines or antibody therapies might need to be adapted for the next season.

The monitoring has expanded further to include human metapneumovirus, parvovirus, and parainfluenza virus. These pathogens are not subject to mandatory reporting in Switzerland, but Stadler noted they contribute to the disease burden, especially among vulnerable populations. "At the moment, we only have a limited understanding of the dynamics of these pathogens because barely any data is collected," she said. Most people experience only mild symptoms when infected, but severe cases involving serious respiratory diseases can occur in infants and older adults.

Wastewater monitoring works because everyone leaves traces in the water: by using the toilet, washing hands, brushing teeth, or showering. At wastewater treatment plants, small samples are automatically taken throughout the day, just before the water is cleaned. If people in the catchment area are infected, the wastewater contains virus fragments, which researchers detect in the lab using highly sensitive techniques. They are typically looking for fragments, not complete, contagious viruses.

Stadler's team also studies how viruses mutate. By detecting changes in the genetic sequence, they can use clinical data to assess whether vaccine protection will remain effective against circulating strains. "At the start of a flu season, we also get indications about how effective the vaccine in use is likely to be," she said.

Looking ahead, Stadler envisions a smartphone application similar to a weather app that would allow non-experts to see how much a certain pathogen is spreading. "One look at a weather app and you know whether to take an umbrella, one look at a pathogen app and you know whether to take a mask for public transport," she said. Currently, the WISE platform requires a certain level of prior knowledge to interpret.

The team has already developed lab procedures for additional viruses, including seasonal coronaviruses, mpox, and viruses affecting the digestive tract. However, which viruses are regularly surveyed depends on the needs and financial resources of public health authorities. Stadler noted that the team currently has a mandate from the Swiss Federal Office of Public Health to evaluate data from ten wastewater treatment plants, but detailed long-term plans and finances are not fully confirmed. The activities are tied to the revision of the Swiss Epidemics Act, which proposes anchoring environmental monitoring in law.

Stadler is optimistic about pandemic preparedness. "We'd probably be able to detect a new pandemic virus in wastewater before it's seen in our hospitals," she said. AI-assisted methods will enable faster data evaluation. "From the research side, we'd be well-positioned. How this is used by politics is another question, though," she added, noting that willingness to invest in pandemic preparedness remains limited globally.